- •Table of Contents
- •Copyright
- •Dedication
- •Introduction to the eighth edition
- •Online contents
- •List of Illustrations
- •List of Tables
- •1. Pulmonary anatomy and physiology: The basics
- •Anatomy
- •Physiology
- •Abnormalities in gas exchange
- •Suggested readings
- •2. Presentation of the patient with pulmonary disease
- •Dyspnea
- •Cough
- •Hemoptysis
- •Chest pain
- •Suggested readings
- •3. Evaluation of the patient with pulmonary disease
- •Evaluation on a macroscopic level
- •Evaluation on a microscopic level
- •Assessment on a functional level
- •Suggested readings
- •4. Anatomic and physiologic aspects of airways
- •Structure
- •Function
- •Suggested readings
- •5. Asthma
- •Etiology and pathogenesis
- •Pathology
- •Pathophysiology
- •Clinical features
- •Diagnostic approach
- •Treatment
- •Suggested readings
- •6. Chronic obstructive pulmonary disease
- •Etiology and pathogenesis
- •Pathology
- •Pathophysiology
- •Clinical features
- •Diagnostic approach and assessment
- •Treatment
- •Suggested readings
- •7. Miscellaneous airway diseases
- •Bronchiectasis
- •Cystic fibrosis
- •Upper airway disease
- •Suggested readings
- •8. Anatomic and physiologic aspects of the pulmonary parenchyma
- •Anatomy
- •Physiology
- •Suggested readings
- •9. Overview of diffuse parenchymal lung diseases
- •Pathology
- •Pathogenesis
- •Pathophysiology
- •Clinical features
- •Diagnostic approach
- •Suggested readings
- •10. Diffuse parenchymal lung diseases associated with known etiologic agents
- •Diseases caused by inhaled inorganic dusts
- •Hypersensitivity pneumonitis
- •Drug-induced parenchymal lung disease
- •Radiation-induced lung disease
- •Suggested readings
- •11. Diffuse parenchymal lung diseases of unknown etiology
- •Idiopathic pulmonary fibrosis
- •Other idiopathic interstitial pneumonias
- •Pulmonary parenchymal involvement complicating systemic rheumatic disease
- •Sarcoidosis
- •Miscellaneous disorders involving the pulmonary parenchyma
- •Suggested readings
- •12. Anatomic and physiologic aspects of the pulmonary vasculature
- •Anatomy
- •Physiology
- •Suggested readings
- •13. Pulmonary embolism
- •Etiology and pathogenesis
- •Pathology
- •Pathophysiology
- •Clinical features
- •Diagnostic evaluation
- •Treatment
- •Suggested readings
- •14. Pulmonary hypertension
- •Pathogenesis
- •Pathology
- •Pathophysiology
- •Clinical features
- •Diagnostic features
- •Specific disorders associated with pulmonary hypertension
- •Suggested readings
- •15. Pleural disease
- •Anatomy
- •Physiology
- •Pleural effusion
- •Pneumothorax
- •Malignant mesothelioma
- •Suggested readings
- •16. Mediastinal disease
- •Anatomic features
- •Mediastinal masses
- •Pneumomediastinum
- •Suggested readings
- •17. Anatomic and physiologic aspects of neural, muscular, and chest wall interactions with the lungs
- •Respiratory control
- •Respiratory muscles
- •Suggested readings
- •18. Disorders of ventilatory control
- •Primary neurologic disease
- •Cheyne-stokes breathing
- •Control abnormalities secondary to lung disease
- •Sleep apnea syndrome
- •Suggested readings
- •19. Disorders of the respiratory pump
- •Neuromuscular disease affecting the muscles of respiration
- •Diaphragmatic disease
- •Disorders affecting the chest wall
- •Suggested readings
- •20. Lung cancer: Etiologic and pathologic aspects
- •Etiology and pathogenesis
- •Pathology
- •Suggested readings
- •21. Lung cancer: Clinical aspects
- •Clinical features
- •Diagnostic approach
- •Principles of therapy
- •Bronchial carcinoid tumors
- •Solitary pulmonary nodule
- •Suggested readings
- •22. Lung defense mechanisms
- •Physical or anatomic factors
- •Antimicrobial peptides
- •Phagocytic and inflammatory cells
- •Adaptive immune responses
- •Failure of respiratory defense mechanisms
- •Augmentation of respiratory defense mechanisms
- •Suggested readings
- •23. Pneumonia
- •Etiology and pathogenesis
- •Pathology
- •Pathophysiology
- •Clinical features and initial diagnosis
- •Therapeutic approach: General principles and antibiotic susceptibility
- •Initial management strategies based on clinical setting of pneumonia
- •Suggested readings
- •24. Bacterial and viral organisms causing pneumonia
- •Bacteria
- •Viruses
- •Intrathoracic complications of pneumonia
- •Respiratory infections associated with bioterrorism
- •Suggested readings
- •25. Tuberculosis and nontuberculous mycobacteria
- •Etiology and pathogenesis
- •Definitions
- •Pathology
- •Pathophysiology
- •Clinical manifestations
- •Diagnostic approach
- •Principles of therapy
- •Nontuberculous mycobacteria
- •Suggested readings
- •26. Miscellaneous infections caused by fungi, including Pneumocystis
- •Fungal infections
- •Pneumocystis infection
- •Suggested readings
- •27. Pulmonary complications in the immunocompromised host
- •Acquired immunodeficiency syndrome
- •Pulmonary complications in non–HIV immunocompromised patients
- •Suggested readings
- •28. Classification and pathophysiologic aspects of respiratory failure
- •Definition of respiratory failure
- •Classification of acute respiratory failure
- •Presentation of gas exchange failure
- •Pathogenesis of gas exchange abnormalities
- •Clinical and therapeutic aspects of hypercapnic/hypoxemic respiratory failure
- •Suggested readings
- •29. Acute respiratory distress syndrome
- •Physiology of fluid movement in alveolar interstitium
- •Etiology
- •Pathogenesis
- •Pathology
- •Pathophysiology
- •Clinical features
- •Diagnostic approach
- •Treatment
- •Suggested readings
- •30. Management of respiratory failure
- •Goals and principles underlying supportive therapy
- •Mechanical ventilation
- •Selected aspects of therapy for chronic respiratory failure
- •Suggested readings
- •Index
30: Management of respiratory failure
OUTLINE
Goals and Principles Underlying Supportive Therapy, 349
Acute Hypoxemic Respiratory Failure, 350
Hypercapnic Respiratory Failure, 351
Reducing Work of Breathing, 352
Mechanical Ventilation, 352
Pressure-Limited Ventilation, 352
Volume-Cycled Ventilation, 353
Positive End-Expiratory Pressure, 354
Other Ventilatory Strategies, 355
Discontinuation of Ventilatory Support, 355
Noninvasive Ventilatory Support for Acute Respiratory Failure, 356
Complications of Intubation and Mechanical Ventilation, 356
Selected Aspects of Therapy for Chronic Respiratory Failure, 358
Chronic Ventilatory Support, 358
Lung Transplantation, 359
Supportive therapy aimed at maintaining adequate gas exchange is critical in the management of both acute respiratory failure and chronic respiratory insufficiency. In acute respiratory failure, survival depends on the ability to provide supportive therapy until the patient recovers from the acute illness that precipitated the need to support the respiratory system. In patients with chronic respiratory insufficiency, the goal is to maximize the patient’s function and minimize symptoms and cor pulmonale on a long-term basis. This chapter outlines the goals and methods of supportive therapy, focusing on various aspects of mechanical ventilation and strategies for maintaining adequate gas exchange. Because the principles for supportive management differ in acute hypoxemic respiratory failure (e.g., acute respiratory distress syndrome [ARDS]) and in hypercapnic respiratory failure (e.g., acute-on-chronic respiratory failure, as in chronic obstructive pulmonary disease [COPD] or neuromuscular disease), these categories are
considered separately. The chapter concludes with a consideration of two specific topics applicable to
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
patients with chronic respiratory insufficiency: chronic ventilatory assistance and lung transplantation.
Goals and principles underlying supportive therapy
Adequate uptake of O2 by the blood, delivery of O2 to the tissues, and elimination of CO2 all are components of normal gas exchange. In terms of O2 uptake by the blood, almost all of the O2 carried by blood is bound to hemoglobin, and only a small portion is dissolved in plasma. It is apparent from the oxyhemoglobin dissociation curve that elevating PO2 beyond the point at which hemoglobin is almost completely saturated does not significantly increase the O2 content of blood (see Chapter 1). On average, assuming that the oxyhemoglobin dissociation curve is not shifted, hemoglobin is approximately 90% saturated at a PO2 of 60 mm Hg. Increasing PO2 to this level is important for tissue oxygen delivery, but a PO2 much beyond this level does not provide that much incremental benefit. In practice, patients with respiratory failure often are maintained at a PO2 slightly higher than 60 mm Hg (or an O2 saturation slightly > 90%) to allow a “margin of safety” for fluctuations in oxygenation.
Goals of optimizing O2 transport to tissues:
1.Arterial O2 saturation greater than 90% (i.e., PO2 > 60 mm Hg)
2.Acceptable hemoglobin level (e.g., ≥7 g/dL)
3.Appropriate cardiac output
Oxygen delivery to the tissues, however, depends not only on arterial PO2 but also on hemoglobin concentration and cardiac output. In patients who are anemic, O2 content and thus O2 transport can be compromised as much by the low hemoglobin level as by hypoxemia (see Eq. 1.3). In selected circumstances, blood transfusion may be useful in raising the hemoglobin and O2 content to more desirable levels, usually in order to maintain a hemoglobin concentration ≥ 7 g/dL.
Similarly, when cardiac output is impaired, tissue O2 delivery also decreases, and measures to augment cardiac output may improve overall O2 transport and delivery. Unfortunately, the use of positive-pressure ventilation, particularly with positive end-expiratory pressure (PEEP), may have a detrimental effect on cardiac output. As a result, tissue O2 delivery may not improve (and even may worsen) despite an increase in PO2. The use of PEEP is discussed in more detail later in this chapter.
Elimination of CO2 by the lungs is important for maintaining adequate acid-base homeostasis. However, achieving an acceptable pH value, not a “normal” PCO2 of 40 mm Hg, is the primary goal in managing respiratory failure with impaired elimination of CO2. In patients with chronic hypercapnia (and metabolic compensation), abruptly restoring PCO2 to 40 mm Hg may cause significant alkalosis and thus risk precipitating either arrhythmias or seizures.
CO2 elimination is manipulated to maintain acceptable pH rather than “normal” PCO2 of 40 mm Hg.
Acute hypoxemic respiratory failure
In the patient with acute hypoxemic respiratory failure such as due to ARDS, ventilation-perfusion mismatch and shunting are responsible for the hypoxemia. Because a large fraction of the cardiac output is
being shunted through areas of unventilated lung and is therefore not oxygenated during passage through the lungs, supplemental O2 is relatively ineffective at raising PO2 to an acceptable level. In these cases, patients may require inspired O2 concentrations in the range of 60% to 100% and still may have difficulty maintaining PO2 greater than 60 mm Hg.
Such patients with ARDS typically require ventilatory assistance for support of oxygenation and relief from a high work of breathing resulting from stiff, noncompliant lungs that are filled with fluid. Although oxygenation is extremely difficult to support, CO2 retention is much less frequent in patients with ARDS, and hypoxemia rather than hypercapnia is the primary indication for mechanical ventilation.
For patients with acute hypoxemic respiratory failure, inability to achieve a PO2 of 60 mm Hg or greater on supplemental O2 readily administered by face mask or heated high-flow nasal cannula with an oxygen blender (generally delivering a fractional concentration of inspired oxygen [FiO2] of 70%-100%) is often considered a justification for intubation (i.e., placement of a flexible plastic endotracheal tube through the nose or mouth, between the vocal cords, and into the trachea). A mechanical ventilator is then connected to the endotracheal tube to provide the desired inspiratory gas under positive pressure. However, such decisions for ventilatory support are not based on just one number. Other factors taken into consideration include the nature of the underlying problem and the likelihood of a rapid response to therapy.
Mechanical ventilation is often indicated when PO2 ≥ 60 mm Hg cannot be achieved with inspired O2 concentration ≤ 70% to 100%.
In the setting of ARDS, intubation and mechanical ventilation serve several useful purposes. First, higher concentrations of O2 can be administered much more reliably through a tube inserted into the trachea than through a mask placed over the face. Second, administration of positive pressure by a ventilator relieves the patient of the high work of breathing (see section “Reducing Work of Breathing”), allowing patients to receive more reliable tidal volumes than they would spontaneously take, particularly because the poorly compliant lungs of ARDS promote shallow breathing and low tidal volumes. Finally, when a tube is in place in the trachea, positive pressure can be maintained in the airway throughout the entire respiratory cycle rather than in just roughly one-half of it. In common usage, positive airway pressure maintained at the end of expiration in a mechanically ventilated patient is termed PEEP, which is described in more detail later in this chapter.
Beneficial effects of ventilatory assistance in acute respiratory distress syndrome (ARDS):
1.More reliable administration of high concentrations of inspired O2
2.Delivery of more reliable tidal volumes than those achieved spontaneously by the patient
3.Use of positive end-expiratory pressure (PEEP)
Why is positive pressure throughout the respiratory cycle beneficial for ARDS patients? In ARDS, fluid occupying alveolar spaces, low tidal volumes, and probably both decreased production and inactivation of surfactant result in microatelectasis and in decreased or absent ventilation to involved areas of the lung. The resting end-expiratory volume (i.e., functional residual capacity [FRC]) is decreased, and continued perfusion of nonventilated alveoli results in an elevation of the fraction of blood that is shunted through the lungs without being oxygenated. With administration of PEEP, FRC is
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
increased, and many small airways and alveoli that formerly were collapsed and received no ventilation are now opened and available for gas exchange. Measurement of the “shunt fraction” shows that PEEP is quite effective at decreasing the amount of blood that otherwise would not be oxygenated during passage through the lungs.
PEEP is effective in ARDS by increasing functional residual capacity (FRC), preventing closure of small airways and alveoli, and decreasing the shunt fraction.
When the shunt fraction is decreased by PEEP, supplemental O2 is much more effective at elevating the patient’s PO2 to an acceptable level. The concentration of inspired O2 thus can be lowered, and the patient is less likely to experience O2 toxicity from sustained exposure to very high concentrations of O2.
Hypercapnic respiratory failure
CO2 retention is an important aspect of respiratory failure in several types of patients. Most frequently, these patients have some degree of chronic CO2 retention, and their acute problem is appropriately termed acute-on-chronic respiratory failure. Patients with chronic obstructive lung disease, chest wall disease, and neuromuscular disease are all subject to the development of hypercapnia. Hypercapnia may be purely acute in certain other groups of patients—individuals who have suppressed respiratory drive resulting from ingestion of certain drugs, especially narcotics, or occasional patients with severe asthma and status asthmaticus.
If the degree of CO2 retention is sufficiently great to cause a marked decrease in the patient’s pH (<7.25 to 7.30) or a change in mental status, ventilatory assistance with a mechanical ventilator is often necessary. Traditionally, ventilator support has been initiated following endotracheal intubation. Although this type of invasive mechanical ventilation through an endotracheal tube may be required for patients with more extreme hypercapnia or with changes in mental status, most patients with hypercapnia from an acute exacerbation of chronic obstructive lung disease, neuromuscular disease, chest wall disease, or heart failure now are managed initially using noninvasive positive-pressure ventilation (NIPPV). With NIPPV, the mechanical ventilator delivers positive pressure via a tight-fitting face mask rather than an endotracheal tube, and the need for intubating the trachea and sedating the patient can often be averted.
Mechanical ventilation for patients with hypercapnic respiratory failure often is provided initially with noninvasive positive-pressure ventilation.
Most cases of hypercapnic respiratory failure are also associated with some degree of hypoxemia, due to hypoventilation as well as ventilation-perfusion mismatch that accompanies the underlying disease. For these mechanisms of hypoxemia, administration of supplemental O2 is quite effective in improving PO2, and high concentrations of inspired O2 are usually not necessary. As previously noted in Chapter 18, patients with chronic hypercapnia may be subject to further increases in PCO2 when they receive supplemental O2. If PCO2 rises significantly after administration of supplemental O2 in a patient not already receiving ventilatory assistance, NIPPV should be started. Fortunately, this complication of significant hypercapnia is infrequent with judicious use of supplemental O2.
Reducing work of breathing
One pathophysiologic feature shared by most patients with respiratory failure is an imbalance in the work